APO Research, Inc.

APO RESEARCH · REPORT

AI Image-assisted Diagnosis Software

Selected research

Market Outlook & Growth Opportunities

Global AI Image-assisted Diagnosis Software Market Outlook and Growth Opportunities 2026

Market perspective

The global AI Image-assisted Diagnosis Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Image-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Image-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Image-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Image-assisted Diagnosis Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Image-assisted Diagnosis Software market include KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO), Solvision, IBM Watson, Butterfly Network, Arterys, Zebra Medical Vision, Freenome, MIT Technology Review and Lunit, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Image-assisted Diagnosis Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Image-assisted Diagnosis Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Image-assisted Diagnosis Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Image-assisted Diagnosis Software market.

AI Image-assisted Diagnosis Software Segment by Company

KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)

Solvision

IBM Watson

Butterfly Network

Arterys

Zebra Medical Vision

Freenome

MIT Technology Review

Lunit

DiA Imaging

RetinAi

Subtle Medical

BrainMiner

AI Image-assisted Diagnosis Software Segment by Type

Ultrasound Image

Radiographic Image

Radiation Therapy

Pathological Analysis

Endoscopic Image

AI Image-assisted Diagnosis Software Segment by Application

Hospital

Ambulatory Surgery Center

AI Image-assisted Diagnosis Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Image-assisted Diagnosis Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Image-assisted Diagnosis Software key companies, revenue, market share, and recent developments.

3. To split the AI Image-assisted Diagnosis Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Image-assisted Diagnosis Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Image-assisted Diagnosis Software significant trends, drivers, influence factors in global and regions.

6. To analyze AI Image-assisted Diagnosis Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Image-assisted Diagnosis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Image-assisted Diagnosis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Image-assisted Diagnosis Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Image-assisted Diagnosis Software industry.

Chapter 3: Detailed analysis of AI Image-assisted Diagnosis Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Image-assisted Diagnosis Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Image-assisted Diagnosis Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Image-assisted Diagnosis Software Industry Trends Table 2. AI Image-assisted Diagnosis Software Industry Drivers Table 3. AI Image-assisted Diagnosis Software Industry Opportunities and Challenges Table 4. AI Image-assisted Diagnosis Software Industry Restraints Table 5. Global AI Image-assisted Diagnosis Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Image-assisted Diagnosis Software Revenue Share by Company (2021-2026) Table 7. Global AI Image-assisted Diagnosis Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Image-assisted Diagnosis Software Key Company Manufacturing Base & Headquarters Table 9. Global AI Image-assisted Diagnosis Software Company, Product Type & Application Table 10. Global AI Image-assisted Diagnosis Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Image-assisted Diagnosis Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Ultrasound Image Table 15. Significant Companies of Radiographic Image Table 16. Significant Companies of Radiation Therapy Table 17. Significant Companies of Pathological Analysis Table 18. Significant Companies of Endoscopic Image Table 19. Global AI Image-assisted Diagnosis Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global AI Image-assisted Diagnosis Software Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global AI Image-assisted Diagnosis Software Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global AI Image-assisted Diagnosis Software Sales Value Share by Type (2021-2026) Table 23. Global AI Image-assisted Diagnosis Software Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hospital Table 25. Significant Companies of Ambulatory Surgery Center Table 26. Global AI Image-assisted Diagnosis Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global AI Image-assisted Diagnosis Software Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global AI Image-assisted Diagnosis Software Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global AI Image-assisted Diagnosis Software Sales Value Share by Application (2021-2026) Table 30. Global AI Image-assisted Diagnosis Software Sales Value Share by Application (2027-2032) Table 31. Global AI Image-assisted Diagnosis Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AI Image-assisted Diagnosis Software Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global AI Image-assisted Diagnosis Software Sales Value Share by Region (2021-2026) Table 34. Global AI Image-assisted Diagnosis Software Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global AI Image-assisted Diagnosis Software Sales Value Share by Region (2027-2032) Table 36. Global AI Image-assisted Diagnosis Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global AI Image-assisted Diagnosis Software Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global AI Image-assisted Diagnosis Software Sales Value Market Share by Country (2021-2026) Table 39. Global AI Image-assisted Diagnosis Software Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global AI Image-assisted Diagnosis Software Sales Value Market Share by Country (2027-2032) Table 41. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Company Information Table 42. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Business Overview Table 43. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) AI Image-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) AI Image-assisted Diagnosis Software Product Portfolio Table 45. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Recent Development Table 46. Solvision Company Information Table 47. Solvision Business Overview Table 48. Solvision AI Image-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Solvision AI Image-assisted Diagnosis Software Product Portfolio Table 50. Solvision Recent Development Table 51. IBM Watson Company Information Table 52. IBM Watson Business Overview Table 53. IBM Watson AI Image-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. IBM Watson AI Image-assisted Diagnosis Software Product Portfolio Table 55. IBM Watson Recent Development Table 56. Butterfly Network Company Information Table 57. Butterfly Network Business Overview Table 58. Butterfly Network AI Image-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Butterfly Network AI Image-assisted Diagnosis Software Product Portfolio Table 60. Butterfly Network Recent Development Table 61. Arterys Company Information Table 62. Arterys Business Overview Table 63. Arterys AI Image-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Arterys AI Image-assisted Diagnosis Software Product Portfolio Table 65. Arterys Recent Development Table 66. Zebra Medical Vision Company Information Table 67. Zebra Medical Vision Business Overview Table 68. Zebra Medical Vision AI Image-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Zebra Medical Vision AI Image-assisted Diagnosis Software Product Portfolio Table 70. Zebra Medical Vision Recent Development Table 71. Freenome Company Information Table 72. Freenome Business Overview Table 73. Freenome AI Image-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Freenome AI Image-assisted Diagnosis Software Product Portfolio Table 75. Freenome Recent Development Table 76. MIT Technology Review Company Information Table 77. MIT Technology Review Business Overview Table 78. MIT Technology Review AI Image-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. MIT Technology Review AI Image-assisted Diagnosis Software Product Portfolio Table 80. MIT Technology Review Recent Development Table 81. Lunit Company Information Table 82. Lunit Business Overview Table 83. Lunit AI Image-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Lunit AI Image-assisted Diagnosis Software Product Portfolio Table 85. Lunit Recent Development Table 86. DiA Imaging Company Information Table 87. DiA Imaging Business Overview Table 88. DiA Imaging AI Image-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. DiA Imaging AI Image-assisted Diagnosis Software Product Portfolio Table 90. DiA Imaging Recent Development Table 91. RetinAi Company Information Table 92. RetinAi Business Overview Table 93. RetinAi AI Image-assisted Diagnosis Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. RetinAi AI Image-assisted Diagnosis Software Product Portfolio Table 95. RetinAi Recent Development Table 96. Subtle Medical Company Information Table 97. Subtle Medical Business Overview Table 98. Subtle Medical AI Image-assisted Diagnosis Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Subtle Medical AI Image-assisted Diagnosis Software Product Portfolio Table 100. Subtle Medical Recent Development Table 101. BrainMiner Company Information Table 102. BrainMiner Business Overview Table 103. BrainMiner AI Image-assisted Diagnosis Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. BrainMiner AI Image-assisted Diagnosis Software Product Portfolio Table 105. BrainMiner Recent Development Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. AI Image-assisted Diagnosis Software Product Image Figure 2. Global AI Image-assisted Diagnosis Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Image-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Image-assisted Diagnosis Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Ultrasound Image Image Figure 8. Radiographic Image Image Figure 9. Radiation Therapy Image Figure 10. Pathological Analysis Image Figure 11. Endoscopic Image Image Figure 12. Global AI Image-assisted Diagnosis Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global AI Image-assisted Diagnosis Software Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global AI Image-assisted Diagnosis Software Sales Value Share by Type (2021-2032) Figure 15. Hospital Image Figure 16. Ambulatory Surgery Center Image Figure 17. Global AI Image-assisted Diagnosis Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global AI Image-assisted Diagnosis Software Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global AI Image-assisted Diagnosis Software Sales Value Share by Application (2021-2032) Figure 20. Global AI Image-assisted Diagnosis Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global AI Image-assisted Diagnosis Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America AI Image-assisted Diagnosis Software Sales Value (2021-2032) & (US$ Million) Figure 23. North America AI Image-assisted Diagnosis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe AI Image-assisted Diagnosis Software Sales Value (2021-2032) & (US$ Million) Figure 25. Europe AI Image-assisted Diagnosis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific AI Image-assisted Diagnosis Software Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific AI Image-assisted Diagnosis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America AI Image-assisted Diagnosis Software Sales Value (2021-2032) & (US$ Million) Figure 29. South America AI Image-assisted Diagnosis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa AI Image-assisted Diagnosis Software Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa AI Image-assisted Diagnosis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Ultrasound Image
  • Radiographic Image
  • Radiation Therapy
  • Pathological Analysis
  • Endoscopic Image
Applications
  • Hospital
  • Ambulatory Surgery Center
Companies covered
  • KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)
  • Solvision
  • IBM Watson
  • Butterfly Network
  • Arterys
  • Zebra Medical Vision
  • Freenome
  • MIT Technology Review
  • Lunit
  • DiA Imaging
  • RetinAi
  • Subtle Medical
  • BrainMiner

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Image-assisted Diagnosis Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Image-assisted Diagnosis Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Image-assisted Diagnosis Software Market Dynamics
  1. 2.1 AI Image-assisted Diagnosis Software Industry Trends
  2. 2.2 AI Image-assisted Diagnosis Software Industry Drivers
  3. 2.3 AI Image-assisted Diagnosis Software Industry Opportunities and Challenges
  4. 2.4 AI Image-assisted Diagnosis Software Industry Restraints
3 AI Image-assisted Diagnosis Software Market by Company
  1. 3.1 Global AI Image-assisted Diagnosis Software Company Revenue Ranking in 2025
  2. 3.2 Global AI Image-assisted Diagnosis Software Revenue by Company (2021-2026)
  3. 3.3 Global AI Image-assisted Diagnosis Software Company Ranking (2024-2026)
  4. 3.4 Global AI Image-assisted Diagnosis Software Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Image-assisted Diagnosis Software Company Product Type and Application
  6. 3.6 Global AI Image-assisted Diagnosis Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Image-assisted Diagnosis Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Image-assisted Diagnosis Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Image-assisted Diagnosis Software Market by Type
  1. 4.1 AI Image-assisted Diagnosis Software Type Introduction
  2. 4.1.1 Ultrasound Image
  3. 4.1.2 Radiographic Image
  4. 4.1.3 Radiation Therapy
  5. 4.1.4 Pathological Analysis
  6. 4.1.5 Endoscopic Image
  7. 4.2 Global AI Image-assisted Diagnosis Software Sales Value by Type
  8. 4.2.1 Global AI Image-assisted Diagnosis Software Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global AI Image-assisted Diagnosis Software Sales Value by Type (2021-2032)
  10. 4.2.3 Global AI Image-assisted Diagnosis Software Sales Value Share by Type (2021-2032)
5 AI Image-assisted Diagnosis Software Market by Application
  1. 5.1 AI Image-assisted Diagnosis Software Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Ambulatory Surgery Center
  4. 5.2 Global AI Image-assisted Diagnosis Software Sales Value by Application
  5. 5.2.1 Global AI Image-assisted Diagnosis Software Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global AI Image-assisted Diagnosis Software Sales Value by Application (2021-2032)
  7. 5.2.3 Global AI Image-assisted Diagnosis Software Sales Value Share by Application (2021-2032)
6 AI Image-assisted Diagnosis Software Regional Value Analysis
  1. 6.1 Global AI Image-assisted Diagnosis Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Image-assisted Diagnosis Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Image-assisted Diagnosis Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Image-assisted Diagnosis Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Image-assisted Diagnosis Software Sales Value (2021-2032)
  7. 6.3.2 North America AI Image-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Image-assisted Diagnosis Software Sales Value (2021-2032)
  10. 6.4.2 Europe AI Image-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Image-assisted Diagnosis Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Image-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Image-assisted Diagnosis Software Sales Value (2021-2032)
  16. 6.6.2 South America AI Image-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Image-assisted Diagnosis Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Image-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
7 AI Image-assisted Diagnosis Software Country-level Value Analysis
  1. 7.1 Global AI Image-assisted Diagnosis Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Image-assisted Diagnosis Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Image-assisted Diagnosis Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Image-assisted Diagnosis Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)
  2. 8.1.1 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Company Information
  3. 8.1.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Business Overview
  4. 8.1.3 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) AI Image-assisted Diagnosis Software Product Portfolio
  6. 8.1.5 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Recent Developments
  7. 8.2 Solvision
  8. 8.2.1 Solvision Company Information
  9. 8.2.2 Solvision Business Overview
  10. 8.2.3 Solvision AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Solvision AI Image-assisted Diagnosis Software Product Portfolio
  12. 8.2.5 Solvision Recent Developments
  13. 8.3 IBM Watson
  14. 8.3.1 IBM Watson Company Information
  15. 8.3.2 IBM Watson Business Overview
  16. 8.3.3 IBM Watson AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 IBM Watson AI Image-assisted Diagnosis Software Product Portfolio
  18. 8.3.5 IBM Watson Recent Developments
  19. 8.4 Butterfly Network
  20. 8.4.1 Butterfly Network Company Information
  21. 8.4.2 Butterfly Network Business Overview
  22. 8.4.3 Butterfly Network AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Butterfly Network AI Image-assisted Diagnosis Software Product Portfolio
  24. 8.4.5 Butterfly Network Recent Developments
  25. 8.5 Arterys
  26. 8.5.1 Arterys Company Information
  27. 8.5.2 Arterys Business Overview
  28. 8.5.3 Arterys AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Arterys AI Image-assisted Diagnosis Software Product Portfolio
  30. 8.5.5 Arterys Recent Developments
  31. 8.6 Zebra Medical Vision
  32. 8.6.1 Zebra Medical Vision Company Information
  33. 8.6.2 Zebra Medical Vision Business Overview
  34. 8.6.3 Zebra Medical Vision AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Zebra Medical Vision AI Image-assisted Diagnosis Software Product Portfolio
  36. 8.6.5 Zebra Medical Vision Recent Developments
  37. 8.7 Freenome
  38. 8.7.1 Freenome Company Information
  39. 8.7.2 Freenome Business Overview
  40. 8.7.3 Freenome AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Freenome AI Image-assisted Diagnosis Software Product Portfolio
  42. 8.7.5 Freenome Recent Developments
  43. 8.8 MIT Technology Review
  44. 8.8.1 MIT Technology Review Company Information
  45. 8.8.2 MIT Technology Review Business Overview
  46. 8.8.3 MIT Technology Review AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MIT Technology Review AI Image-assisted Diagnosis Software Product Portfolio
  48. 8.8.5 MIT Technology Review Recent Developments
  49. 8.9 Lunit
  50. 8.9.1 Lunit Company Information
  51. 8.9.2 Lunit Business Overview
  52. 8.9.3 Lunit AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lunit AI Image-assisted Diagnosis Software Product Portfolio
  54. 8.9.5 Lunit Recent Developments
  55. 8.10 DiA Imaging
  56. 8.10.1 DiA Imaging Company Information
  57. 8.10.2 DiA Imaging Business Overview
  58. 8.10.3 DiA Imaging AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 DiA Imaging AI Image-assisted Diagnosis Software Product Portfolio
  60. 8.10.5 DiA Imaging Recent Developments
  61. 8.11 RetinAi
  62. 8.11.1 RetinAi Company Information
  63. 8.11.2 RetinAi Business Overview
  64. 8.11.3 RetinAi AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 RetinAi AI Image-assisted Diagnosis Software Product Portfolio
  66. 8.11.5 RetinAi Recent Developments
  67. 8.12 Subtle Medical
  68. 8.12.1 Subtle Medical Company Information
  69. 8.12.2 Subtle Medical Business Overview
  70. 8.12.3 Subtle Medical AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Subtle Medical AI Image-assisted Diagnosis Software Product Portfolio
  72. 8.12.5 Subtle Medical Recent Developments
  73. 8.13 BrainMiner
  74. 8.13.1 BrainMiner Company Information
  75. 8.13.2 BrainMiner Business Overview
  76. 8.13.3 BrainMiner AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 BrainMiner AI Image-assisted Diagnosis Software Product Portfolio
  78. 8.13.5 BrainMiner Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.